Biogen Licenses the Rosetta Resolver Expression Analysis System | GenomeWeb

NEW YORK, April 25 - Biogen has licensed the Rosetta Resolver gene expression analysis system from Rosetta Inpharmatics, the companies said Wednesday.

Biogen will use the Resolver system to manage and analyze its gene expression data, the pharmaceutical company said in a statement. The companies did not disclose financial details of the deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.